Circulating Epithelial Tumor Cell (CETC) Monitoring during SERM and Aromatase Inhibitor Treatment for Early Detection of Patients Resistant to Tamoxifen.

被引：0

作者：

Pachmann, K.

Camara, O.

Rabenstein, C.

Winzer, H.

Runnebaum, I. B.

机构：

[1] Univ Jena, Univ Hosp, Jena, Germany

[2] Transfus Ctr, Bayreuth, Germany

来源：

CANCER RESEARCH | 2009年 / 69卷 / 24期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：808S / 809S

页数：2

共 50 条

[21] Detection and monitoring of circulating endothelial cells, circulating tumor cells and disseminated tumor cells during neoadjuvant breast cancer treatment including bevacizumab [J].

Mathiesen, R. R. ;

Borgen, E. ;

Saetersdal, A. B. ;

Fangberget, A. ;

Schirmer, C. ;

Stav, I. ;

Fagerland, M. W. ;

Wist, E. ;

Engebraten, O. ;

Naume, B. .

CANCER RESEARCH, 2013, 73

[22] Circulating tumor DNA for early relapse detection and monitoring disease status in patients with early-stage pancreatic adenocarcinoma [J].

Abdelrahim, M. ;

Esmail, A. ;

Katz, T. ;

Sharma, S. ;

Kalashnikova, E. ;

Malhotra, M. ;

Olshan, P. ;

Billings, P. ;

Aleshin, A. .

ANNALS OF ONCOLOGY, 2021, 32 :S135-S135

[23] Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy [J].

Mikulova, Veronika ;

Cabinakova, Michaela ;

Janatkova, Ivana ;

Mestek, Otto ;

Zima, Tomas ;

Tesarova, Petra .

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2014, 74 (02) :132-142

[24] Circulating Tumor DNA for Early Relapse Detection and Monitoring Disease Status in Patients With Early-Stage Pancreatic Adenocarcinoma [J].

Abdelrahim, M. ;

Chandana, S. ;

Esmail, A. ;

Katz, T. A. ;

Drummond, B. ;

Sharma, S. ;

Kalashnikova, E. ;

Olshan, P. ;

Billings, P. R. ;

Aleshin, A. .

PANCREAS, 2021, 50 (07) :1044-1045

[25] Switching to aromatase inhibitor (AI) after tamoxifen in premenopausal patients with chemotherapy-induced amenorrhea (CIA) after early breast cancer treatment [J].

Perez-Fidalgo, J. A. ;

Miranda, M. J. ;

Bermejo, B. ;

Pons, V. ;

Rosello, S. ;

Garcia-Garre, E. ;

Guzman, C. ;

Lluch, A. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

[26] Arthralgia During Aromatase Inhibitor Treatment in Early Breast Cancer Patients Prevalence, Impact, and Recognition by Healthcare Providers [J].

Boonstra, Amilie ;

van Zadelhoff, Joost ;

Timmer-Bonte, Anja ;

Ottevanger, Petronella B. ;

Beurskens, Carien H. G. ;

van Laarhoven, Hanneke W. M. .

CANCER NURSING, 2013, 36 (01) :52-59

[27] Supervising circulating tumor cells during and beyond maintenance therapy with SERM or aromatase inhibitors. A way to better support our patients to make decisions in long-term survivorship [J].

Pachmann, K. ;

Rabenstein, C. ;

Camara, O. ;

Ingo, R. B. ;

Ulrich, P. .

CANCER RESEARCH, 2013, 73

[28] Demasking of epithelial cell adhesion molecule (EpCAM) on circulating epithelial tumor cells by Tween®20 treatment in breast cancer patients [J].

Hekimian, Katya ;

Stein, Ernst-Ludwig ;

Pachmann, Ulrich ;

Pachmann, Katharina .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (04) :701-708

[29] Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker [J].

Hofman, Veronique ;

Bonnetaud, Christelle ;

Ilie, Marius I. ;

Vielh, Philippe ;

Vignaud, Jean Michel ;

Flejou, Jean Francois ;

Lantuejoul, Sylvie ;

Piaton, Eric ;

Mourad, Nadine ;

Butori, Catherine ;

Selva, Eric ;

Poudenx, Michel ;

Sibon, Stephanie ;

Kelhef, Sabrina ;

Venissac, Nicolas ;

Jais, Jean-Philippe ;

Mouroux, Jerome ;

Molina, Thierry Jo ;

Hofman, Paul .

CLINICAL CANCER RESEARCH, 2011, 17 (04) :827-835

[30] Circulating tumor cell detection predicts early recurrence in patients with non-metastatic breast cancer [J].

Hall, C. ;

Meas, S. ;

Bauldry, J. Bowman ;

Kuerer, H. ;

Lucci, A. .

CANCER RESEARCH, 2019, 79 (04)

← 1 2 3 4 5 →